Delivery Order SPE2DB20D1109-SPE2DB25FP82D
Award Date 9/24/25
Potential Completion Date 10/16/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $16,543.30 delivery order (Contract 4569422403) to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,696.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.90 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.9 million through December 2026. ProQuad is a combination vaccine used to protect...
- The Defense Logistics Agency (DLA) awarded a $1,687.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 19, 2025, with a completion date of September 10, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $2,686.44 to AmerisourceBergen Drug Corp for ProQuad vials on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement under the company's existing DLA contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,374.96 to AmerisourceBergen Drug Corp for ProQuad vials on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026. The contract is non-set-aside and was competitively awarded,...
- The Defense Logistics Agency awarded a delivery order valued at $3,374.88 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The delivery order will be fulfilled at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of ProQuad vials with a ceiling value of $16,543.30 and ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...